01

Sep

2015

05:00

BST

Live Stream

Contemporary Management of Acute Coronary Syndrome (ACS) from Diagnosis to Therapy

Average (ratings)
No ratings
Your rating

Overview

Faculty:

Justin E Davies

Justin E Davies

This live stream is supported by

Agenda

Part 1

Identification and confirmation of ACS diagnosis

Part 2

Evidence basis for diagnostic pathway

Part 3

Pre-procedural work-up and pharmacological regime based on the latest clinical evidence base

Part 4

Invasive diagnostic work-up

Part 5

Assessment of stenosis severity

Part 6

Revascularisation

Part 7

Take Home Messages

Learning Objectives

  • Diagnosis and recognition of acute coronary syndromes as well as risk scoring and stratification
  • Understand the importance of an early invasive approach in reducing cardiac events and adverse outcomes
  • Understand the role of anti-platelets in the management of patient with acute coronary syndromes
  • Understand how to apply the evidence for anti platelets in clinical practice
  • Experience the invasive management of a patient with acute coronary syndrome, including gaining an appreciation of how revacularisation decisions are made, how stenoses are selected for treatment and how revascularisation is performed using state of the a

Target Audience

  • Cardiologists
  • Interventional Cardiologists
  • Other healthcare professionals treating ACS patients

Faculty Biographies

Justin E Davies

Justin E Davies

Dr Justin Davies is a Senior Research Fellow and Consultant Cardiologist at Imperial College London. He also completed his undergraduate training and continued on to complete his PhD at Imperial after being awarded a British Heart Foundation research fellowship.

Now a leading clinical academic in the field of interventional cardiology, Dr Davies has pioneered several new techniques, including coronary wave intensity and instantaneous wave-free ratio (iFR). He is also published extensively in the field of hypertension and coronary and large artery physiology.

View full profile

Key References

1. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014;35:2541–2619. www.ncbi.nlm.nih.gov/pubmed/?term=European+Heart+Journal.+2014%3B35%3A2541%E2%80%932619

2. Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents. N Eng J Med. 2014;371:2155–2166. www.ncbi.nlm.nih.gov/pubmed/?term=New+England+Journal+of+Medicine.+2014%3B371%3A2155%E2%80%932166

3. Bhatt DL, Hulot J-S, Moliterno DJ, et al. Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes. Circ Res. 2014;114:1929–1943. www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+Research.+2014%3B114%3A1929%E2%80%931943

4. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–1057. www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+2009%3B361%3A1045%E2%80%931057